• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Tools & Resources Deeper Look: Opioids

Deeper Look: Opioids

The opioid crisis is one of the greatest public health challenges facing the U.S., causing an unprecedented surge in overdose deaths, and fueling the rapid rise in new Hepatitis C infections from injection drug use in communities across the country.

The opioid crisis is one of the greatest public health challenges facing the U.S., causing an unprecedented surge in overdose deaths, and fueling the rapid rise in new Hepatitis C infections from injection drug use in communities across the country.

As opioid abuse rates have skyrocketed, new Hepatitis C infections have also increased. Data on HepVu show that an estimated 2.4 million Americans were living with Hepatitis C between 2013 and 2016. Though the majority, or roughly three-fourths, of all infections were among Baby Boomers (those born between 1945 and 1965), there has been a spike in new Hepatitis C infections among younger Americans.

The number of new Hepatitis C infections more than doubled from 2012 to 2019, largely reflecting infections due to the rise in injection drug use. This has created a syndemic, in which the opioid and Hepatitis C epidemics are linked – with the burden of Hepatitis C being directly exacerbated by injection drug use.

The Opioid Epidemic

In 2017, the U.S. Department of Health and Human Services (HHS) declared a public health state of emergency due to the opioid epidemic. Opioids are highly addictive and include prescription pain relievers, synthetic compounds such as fentanyl, and illegal drugs such as heroin. The number of deaths due to opioid abuse have more than doubled since 2015, with 91,799 deaths reported in 2020. Males accounted for 69.4% of opioid deaths in 2020 compared to 30.6%.  Synthetic opioids such as fentanyl were the main driver of drug overdose deaths with a nearly 6-fold increase from 2015 to 2020. In 2020, males accounted for 73% of synthetic opioid related deaths with a 6-fold increase from 2015 to 2020 compared to 5-fold increase in women. The opioid epidemic’s growth even contributed to a decrease in annual U.S. life expectancy, which declined to 77.3 years in 2020 primarily be attributed to deaths from the COVID-19 pandemic, although drug overdose deaths accounted for over one-third of all unintentional injury deaths.

The Syndemic

A syndemic refers to two or more interrelated epidemics that are mutually reinforcing and interact in a way that amplifies the overall burden of disease. Although not all people who abuse opioids inject drugs, people who inject drugs are at significantly higher risk of transmission of blood-borne viruses, including HIV and Hepatitis C.

Hepatitis C and HIV can be transmitted by sharing needles, syringes, water, alcohol swabs, and other equipment used to inject drugs. In 62-80% of people who inject drugs co-infection with HIV and Hepatitis C is common. As younger Americans engage in injection drug use, there is also a greater risk of women of childbearing age contracting Hepatitis C and pregnant women exposing their babies to the virus.

The Centers for Disease Control and Prevention (CDC) recommends routine HIV and viral hepatitis screening for people who inject drugs. Additionally, prevention efforts, such as syringe service programs and substance use treatment services, can slow the growth in the number of new Hepatitis C and HIV infections due to injection drug use. By identifying new infections early, patients can be treated for HIV, or cured of Hepatitis C, and stop additional infections from occurring.

Share

Share our infographics with your networks to help raise awareness and understanding of the link between opioids and Hepatitis C.

Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn

4 Ways to Use HepVu

Explore Interactive Maps

Opioid Prescriptions

The rate of retail opioid prescriptions dispensed per 100 people

Learn More

Overdose Mortality

The rate of overdose-related deaths per 100,000 people

Learn More

Pain Reliever Misuse

The percentage of people misusing prescription pain relievers

Learn More

View Local Statistics

View local statistics for your state, and download high-impact data visualizations for your work

See the Data

Download Data

See the Data

Hepatitis C Prevalence

Hepatitis C Mortality

Additional Data

Archived Data

Learn From Experts

Experts weigh in on the opioid epidemic and the resulting syndemic in HepVu’s blog series.

August 23, 2021

Dr. Eric Hall on County-Level Opioid Prescribing and Overdose Mortality Rates

HepVu spoke with Dr. Eric Hall about opioid prescribing and overdose mortality rates at the county-level and understanding the relationship between the two factors across the U.S.

Read More

March 25, 2021

Dr. Gregory Dore on Hepatitis C Treatment Barriers Among People Who Inject Drugs

HepVu spoke with Dr. Gregory Dore about the barriers to Hepatitis C treatment among people who inject drugs in the U.S. and Australia.

Read More

March 18, 2021

Injection Drug Use and Hepatitis C Trends in the Indian Health Service

For National Native HIV/AIDS Awareness Day, Vu spoke with Richard Haverkate, MPH, on the impact of injection drug use on HIV and Hepatitis C in Native communities.

Read More

April 21, 2020

Vu Q&A: Dr. Elinore McCance-Katz on Opioid Use Disorder

Elinore McCance-Katz, MD, PhD, is the first assistant secretary for mental health and substance use and leads the Substance Abuse and Mental Health Services Administration (SAMHSA). Q: In 2017, you were nominated as the first Assistant Secretary for Mental Health and Substance Use and now lead the Substance Abuse and Mental Health Services Administration (SAMHSA).

Read More

January 15, 2019

Vu Q&A: The Opioid Epidemic’s Impact on Hepatitis C in the U.S.

Heather Bradley, Ph.D., is an Assistant Professor of Epidemiology at Georgia State University and serves as HepVu Project Director. Ron Valdiserri, M.D., MPH, is Senior Research Associate and Distinguished Scholar, Johns Hopkins University, Bloomberg School of Public Health, Former Deputy Assistant Secretary for Health, Infectious Diseases, U.S. Department of Health and Human Services, and serves

Read More

May 29, 2018

Vu Q&A: The Opioid Epidemic and Viral Hepatitis in Appalachia

Judith Feinberg has a joint appointment in the West Virginia University School of Medicine as a professor of Behavioral Medicine & Psychiatry and Medicine/Infectious Diseases. She is the Vice Chair of the HIV Medicine Association and a nationally-recognized expert on the opioid epidemic in West Virginia, Appalachia and rural America. Q: The number of new

Read More

January 10, 2018

Addressing Increases in Hepatitis C Infections Linked to the Opioid Epidemic

The other important component of the U.S. Hepatitis C epidemic is smaller in absolute numbers but is the major source of new Hepatitis C infections: infections associated with the opioid epidemic, injection drug use, and the sharing of needles and other drug injection equipment.

Read More

For More Information

Additional information about the opioid and Hepatitis C epidemics can be found at the following resources.

U.S. Centers for Disease Control and Prevention

Opioid Overdose: Understanding the Epidemic

Learn More

National Institute on Drug Abuse

Brief description of opioids

Learn More

amfAR

Opioid & Health Indicators Database

Learn More

U.S. Centers for Disease Control and Prevention

Increase in hepatitis C infections linked to worsening opioid crisis

Learn More

Surgeon General

Facing Addition in America: The Surgeon General’s Spotlight on Opioids (PDF)

Learn More
Share Facebook Twitter LinkedIn Email

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2022 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.